top of page
grey-9026_256.gif

AI-Powered Mental Health Platform Driving Measurable Outcomes

Listing Code:

XYSW2C

State:

Not Disclosed

Category:

Software & Technology

Asking Price:

-

Revenue:

-

XYSW2C
Company Overview

PRIME exits and American HealthCare Capital are pleased to present a unique acquisition opportunity for a technology-enabled mental health platform that is revolutionizing therapeutic outcomes through continuous patient engagement and evidence-based measurement.

This proprietary solution leverages artificial intelligence to provide 24/7 therapeutic support between sessions while generating measurable outcome data that benefits both patients and clinicians. The platform has demonstrated exceptional results, with 91% of patients reporting meaningful improvements within two weeks and maintaining an 86% engagement rate when used with therapy – significantly above industry standards.

Developed in collaboration with PhD psychologists from leading research institutions, the platform’s methodology is validated through peer-reviewed research. The technology delivers personalized therapeutic content and sophisticated progress tracking, enabling clinicians to:

  • Monitor patient progress with clinical-grade measurements

  • Demonstrate improved outcomes to insurance providers

  • Support value-based care initiatives

  • Negotiate better reimbursement rates based on documented results

For patients, the platform provides continuous therapeutic support beyond the session, featuring:

  • AI-driven personalized guidance

  • Evidence-based interventions

  • Progress tracking tools

  • 24/7 emotional support

The company operates in the rapidly expanding digital mental health market, addressing critical gaps in continuous care and outcome measurement. The solution particularly resonates with Gen Z and Millennials, demographics showing the highest demand growth for mental health support.

Financial Overview

The business model features multiple revenue streams including patient subscriptions, clinician subscriptions, insurance reimbursements, and enterprise contracts. Financial projections demonstrate a clear pathway from current revenues to $50M+ within five years, with projected EBITDA margins expanding to 58%.

Key growth opportunities include:

  • Group practice expansion

  • Insurance partnership development

  • Value-based care integration

  • International market penetration

  • Enterprise solution deployment

The platform’s infrastructure is built for scale, with proven technology supporting rapid user growth while maintaining service quality. The founder, who brings deep expertise in both technology and mental health outcomes, is committed to ensuring continued platform success and is open to maintaining a strategic role to support future growth initiatives.

The Opportunity and Exit Strategy

This represents an exceptional opportunity to acquire a validated technology solution with demonstrated clinical outcomes, strong growth metrics, and multiple value creation levers. Detailed financials, clinical outcomes data, and growth plans are available to qualified buyers under NDA.

The founder is open to discussing valuation and exit strategy, ensuring a smooth transition and supporting further growth under new ownership.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

XYSW2C

Listing Title:

AI-Powered Mental Health Platform Driving Measurable Outcomes

Heading 4

Need to learn more before Signing an NDA- Contact the Lead Advisor For This Mandate

Jennifer

Listing Title:

Error
Error

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings

About PRIME exits®

​PRIME exits® is a middle-market M&A advisory firm focused on founder-led, owner-operated, and legacy businesses across Healthcare, Engineering, Manufacturing, Robotics, Automation, and related sectors. We represent business owners seeking a full or partial liquidity event and provide strategic guidance designed to prepare companies for institutional capital, enhance valuation, and position them for successful transactions with strategic acquirers, private equity firms, family offices, and institutional investors.

Our services include exit planning, value enhancement, transaction preparation, buyer identification, negotiation support, and transaction execution. We work closely with founders and executive teams to help maximize shareholder value and achieve their personal and financial objectives.

Important Disclosure

PRIME exits® does not provide legal, tax, accounting, investment, or other regulated professional advice. Clients are encouraged to seek independent advice from qualified legal, tax, accounting, and financial professionals regarding matters specific to their circumstances.

From time to time, PRIME exits® may introduce clients to third-party service providers, including attorneys, accountants, quality of earnings providers, consultants, lenders, valuation experts, and other professionals. Any fees collected on behalf of such third-party providers are processed solely as an administrative convenience. PRIME exits® does not assume responsibility for the services, advice, or work product of any third-party provider.

PRIME exits® is a registered trademark of Nazeri & Company LLC (United States) and Nazeri & Company Co., Ltd. (Thailand), two separate and independent legal entities operating within their respective jurisdictions.

Healthcare-related transactions are conducted through American Healthcare Capital and its affiliated partners, subject to applicable regulatory and licensing requirements.

Through PRIME exits®, American Healthcare Capital, and their affiliated independent managing directors, advisory services are provided across more than 35 virtual office locations throughout the United States, Southeast Asia, and Europe. Each independent managing director operates under separate contractual arrangements and may be subject to jurisdiction-specific licensing, regulatory, and professional requirements.

Locations
bottom of page